BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 13129863)

  • 1. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Hori S
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Shimizu E; Hori S
    Am J Ophthalmol; 2003 Mar; 135(3):321-7. PubMed ID: 12614749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
    Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
    Shimada H; Akaza E; Yuzawa M; Kawashima M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.
    Funatsu H; Yamashita H; Ikeda T; Nakanishi Y; Kitano S; Hori S
    Am J Ophthalmol; 2002 Apr; 133(4):537-43. PubMed ID: 11931788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
    Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Nakamura S; Mimura T; Eguchi S; Noma H; Hori S
    Ophthalmology; 2006 Feb; 113(2):294-301. PubMed ID: 16406543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
    Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of inflammatory factors with macular edema in branch retinal vein occlusion.
    Noma H; Mimura T; Eguchi S
    JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of vitreous inflammatory factors with diabetic macular edema.
    Funatsu H; Noma H; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2009 Jan; 116(1):73-9. PubMed ID: 19118698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring ocular drug therapy by analysis of aqueous samples.
    Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
    Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
    Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.